I am pleased to see industry and thought leaders coming together today for our second annual Foreign Exchange (FX) Market Structure Conference. I look forward to building upon the success of the ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

As logistics networks across the Middle East expand, companies are adopting AI-driven planning models to manage rising ...

Abstract: Digital microfluidics (DMFs) technology provides high-precision and flexible liquid manipulation capabilities for laboratory-on-a-chip (LOC) systems, enabling complex biochemical reactions ...

Abstract: This paper introduces a fully automated, unsupervised technique for detecting step changes in synchrophasor measurements, without prior knowledge or learning data features, without applying ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

There isn’t one tool that can meet all of an enterprise's needs, and teams need the ability to choose different tools for different functionalities.